drugset / Trial / NCT06622239
Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury
Phase 2
Not yet recruiting
150 enrolled
Seoul National University Hospital
Whanin Pharmaceutical Company · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn if naltrexone works to treat nonsuicidal self-injurious behavior in adolescents and adults.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2027-02-28
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | — |
Indications
No indication recorded.